Sign In
Buy TRIB
$11.60
-1.15 (-9.02%)
At Close: Jul 31, 2026
DUBLIN, Ireland, Jan. 31, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) (the “Company”) today announced that it has entered into a non-binding Letter of Intent with Bayer for the lau
Trinity Biotech Announces Acquisition of the CGM Assets of Waveform Technologies, Inc.
07:00am, Wednesday, 31'st Jan 2024
-Repositioning to a rapidly expanding biosensor market with potential for significant growth for the company as part of a revised strategy under our new management
Trinity Biotech plc to Host Investor Call
05:23pm, Tuesday, 30'th Jan 2024
Conference Call Scheduled for Wednesday, January 31, 2024 at 8:30 AM ET Conference Call Scheduled for Wednesday, January 31, 2024 at 8:30 AM ET
Trinity Biotech Announces It Has Begun Shipments of Its New HIV Screening Test, TrinScreen HIV to Kenya
08:57am, Wednesday, 27'th Dec 2023
DUBLIN, Ireland, Dec. 27, 2023 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) (the “Company”), a leading developer and manufacturer of diagnostic products for the point-of-care and clinica
Trinity Biotech Announces Management Changes
04:30pm, Monday, 18'th Dec 2023
John Gillard Named Chief Executive Officer Des Fitzgerald Named Interim Chief Financial Officer DUBLIN, Ireland, Dec. 18, 2023 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) (the “Company”
DUBLIN, Ireland, Nov. 28, 2023 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) (the “Company”), a leading developer and manufacturer of diagnostic solutions for the point-of-care and clinic
Trinity Biotech plc to Announce Second Quarter Fiscal Year 2023 Financial Results
12:50pm, Wednesday, 27'th Sep 2023
DUBLIN, Sept. 27, 2023 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, will r
Trinity Biotech plc to Announce First Quarter Fiscal Year 2023 Financial Results
06:30pm, Monday, 03'rd Jul 2023
DUBLIN, July 03, 2023 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, will re
Trinity Biotech plc to Announce Fourth Quarter and Fiscal Year 2022 Financial Results
03:30pm, Thursday, 16'th Mar 2023
Conference Call Scheduled for March 23, 2023 at 10:00 am EASTERN Conference Call Scheduled for March 23, 2023 at 10:00 am EASTERN
Trinity Biotech plc (TRIB) Q3 2022 Earnings Call Transcript
02:11pm, Thursday, 15'th Dec 2022
Trinity Biotech plc (NASDAQ:TRIB ) Q3 2022 Earnings Conference Call December 15, 2022 11:00 AM ET Company Participants Joe Diaz - Lytham Partners, IR Aris Kekedjian - Chief Executive Officer John Gill
Trinity Biotech plc to Announce Third Quarter Fiscal Year 2022 Financial Results
05:35am, Friday, 09'th Dec 2022
Conference Call Scheduled for December 15, 2022 at 11:00 am EASTERN Conference Call Scheduled for December 15, 2022 at 11:00 am EASTERN
Trinity Biotech plc (TRIB) Q2 2022 Earnings Call Transcript
12:52pm, Saturday, 05'th Nov 2022
Trinity Biotech plc (NASDAQ:TRIB ) Q2 2022 Results Conference Call November 3, 2022 11:00 AM ET Company Participants Joe Diaz - Lytham Partners, IR Aris Kekedjian - Chief Executive Officer John Gillar
Trinity Biotech plc to Announce Second Quarter Fiscal Year 2022 Financial Results
09:15am, Tuesday, 01'st Nov 2022
Conference Call Scheduled for November 3, 2022 at 11:00 am EASTERN Conference Call Scheduled for November 3, 2022 at 11:00 am EASTERN
Trinity Biotech plc (TRIB) CEO Ronan O'Caoimh on Q1 2022 Results - Earnings Call Transcript
03:43pm, Thursday, 30'th Jun 2022
Trinity Biotech plc (NASDAQ:TRIB ) Q1 2022 Earnings Conference Call June 30, 2022 11:00 AM ET Company Participants Joe Diaz - Lytham Partners, IR Ronan O'Caoimh - Chairman and Chief Executive Officer
Trinity Biotech Announces Quarter 1 2022 Financial Results
01:07pm, Thursday, 30'th Jun 2022 GlobeNewswire Inc.
DUBLIN, Ireland, June 30, 2022 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory marke
